3/14/17 17:57 | 3/10/17 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | MI | D | | P.d | 100 | 9.47 | 0 | 11 | 21 | 60 | D | | | -26 | 2 | -12 | -7 | -3 | -3 | 1 | 11 | 24 | | | |
8/12/16 13:19 | 8/10/16 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | MI | D | | P.d | 100 | 10.00 | 0 | 10 | 25 | 49 | D | | | | | | | | 0 | 7 | 13 | 39 | 4 | 14 | |
2/11/15 19:35 | 2/9/15 | AST | Asterias Biotherapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Lichtinger Pedro | CA | DO | CEO | P | 500 | 3.90 | 0 | 128 | 32 | 528 | D | | | 136 | 15 | 20 | -4 | -3 | -1 | -3 | -5 | 80 | 197 | -2 | -23 |
6/6/13 19:04 | 6/4/13 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Lichtinger Pedro | CA | D | | P.d | 0 | 0.00 | 1 | 120 | 999% | 126 | D | -17 | -5 | 12 | -4 | -5 | -3 | -9 | -16 | 0 | -4 | 4 | -7 | -3 | -32 |
4/10/13 21:59 | 4/8/13 | OPTR | Optimer Pharmaceuticals Inc | | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | CA | H | Former C | M.d | 1,878 | 12.69 | 0 | 148 | | 104 | D | | | | | | | | | | | | | | |
4/10/13 21:59 | 4/8/13 | OPTR | Optimer Pharmaceuticals Inc | | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | CA | H | Former C | S.d | -2,174 | 14.69 | 0 | -148 | -59 | 104 | D | | | | | | | | | | | | | | |
11/19/12 19:31 | 11/8/12 | OPTR | Optimer Pharmaceuticals Inc | | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | NJ | O | CEO,P | P | 100 | 9.08 | 0 | 11 | 12 | 104 | D | | | | | | | | | | | | | | |
4/12/12 13:09 | 4/11/12 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Lichtinger Pedro | CA | D | | P.d | 25 | 3.98 | 1 | 6 | New | 6 | D | -41 | -42 | -5 | -31 | -16 | -7 | -5 | -12 | -1 | -7 | -8 | 10 | -4 | -16 |
8/4/11 17:46 | 8/4/11 | OPTR | Optimer Pharmaceuticals Inc | | Health | Drug | Pharmaceutical Preparations | Lichtinger Pedro | CA | DO | CEO,P | P | 224 | 8.98 | 5 | 25 | 38 | 91 | D | -33 | 7 | -13 | -20 | -22 | -14 | -9 | -7 | -3 | -19 | 8 | 56 | 45 | |